Pharmacokinetic profile and first preliminary clinical evaluation of bendamustine in Taiwanese patients with heavily pretreated indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

Author:

Hsiao Liang-Tsai1,Tien Hwei-Fang2,Kuo Ching-Yuan3,Wu Jin-Hou4,Hou Hsin-An2,Wang Ming-Chung3,Liu Chun-Yu1,Chen Po-Min1,Chiou Tzeon-Jye5

Affiliation:

1. Division of Hematology and Oncology, Department of Medicine; Taipei Veterans General Hospital and National Yang-Ming University School of Medicine; Taipei Taiwan

2. Division of Hematology, Department of Internal Medicine; National Taiwan University Hospital, College of Medicine, National Taiwan University; Taipei Taiwan

3. Division of Hematology and Oncology, Department of Internal Medicine; Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine; Kaohsiung Taiwan

4. Division of Hematology and Oncology, Department of Internal Medicine; Taipei Chang Gung Memorial Hospital; Taipei Taiwan

5. Division of Transfusion Medicine, Department of Medicine; Taipei Veterans General Hospital and National Yang-Ming University School of Medicine; Taipei Taiwan

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference32 articles.

1. Cancer facts & figures 2013 http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf

2. Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years;Huang;Cancer,2007

3. The incidence of chronic lymphocytic leukemia in Taiwan, 1986-2005: a distinct increasing trend with birth-cohort effect;Wu;Blood,2010

4. General information about adult non-Hodgkin lymphoma (NHL) 2013 http://www.cancer.gov/cancertopics/pdq/treatment/adult-non-hodgkins/HealthProfessional/page1

5. Karnofsky memorial lecture. The low-grade non-Hodgkin's lymphomas: challenges and opportunities;Rosenberg;J Clin Oncol,1985

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3